Last updated on December 2019

Study Evaluating the One-Year Safety and Efficacy of ABX464 in Patients With Moderate to Severe Rheumatoid Arthritis


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Rheumatoid Arthritis
  • Age: Between 18 - 76 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patients previously enrolled in the ABX464-301 clinical study who have completed the initial 12 weeks of treatment period;

Exclusion Criteria:

  • Any condition, which in the opinion of the investigator, could compromise the patient's safety or adherence to the study protocol

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.